News and Comments

Ariad’s (ARIA) ridaforolimus Brings Hope To Advanced Endometrial Cancer Patients.

  Monday, November 22, 2010

Endometrial cancer is the most common cancer of the female reproductive system. Advanced cases have virtually no effective treatments. Surgery, alone or in combination with radiation, chemotherapy, and/or hormonal therapy are good as initial therapy. In advanced stages, however, surgery has no role to play and chemotherapy has limited, if any, benefit.  More...


Recent Postings


Archive


Tags

Intercept (ICPT) Sarepta (SRPT) Multiple Myeloma Idenix (IDIX) ISIS (ISIS) Jazz Pharmaceuticals (JAZZ) SYNTA (SNTA) Ariad (ARIA) C4 Therapeutics Abbott Laboratories (ABT) Rapamune Sangamo (SGMO) Inovio (INO) ADVENTRIX (ANX) Intrexon (XON) IDERA (IDRA) TOKAI (TKAOI) Amgen (AMGN) Velcade (bortezomib) VANDA (VNDA) Agenus (AGEN) Telaprevir Exelixis (EXEL) Dynavax (DVAX) Illumina (ILMN) Anadys (ANDS) Array Pharmaceuticals (ARRY) Aimmune Therapeutics (AIMT) Roche (ROCHE) Dendreon (DNDN) KITE (KITE) ImmunoGen (IMGN) Anacor (ANAC) Biogen Idec (BIIB) Prolor Biotech (PBTH) SUNESIS PHARMACEUTICALS (SNSS) ZALTRAP™ Ridaforolimus Agenus (AGEN JUNO (JUNO) GUARDIAN HEALTH Benlysta (belimumab) Alnylam (ALNY) KERYX (KERX) GlaxoSmithKline (GSK) Cytokinetics (CYTK) Sequenom (SQNM) Mirati Therapeutics (MRTX) Pluristem (PSTI) Herceptin AERIE PHARMACEUTICALS Endometrial Cancer Valeant Pharmaceuticals International (VRX) Elan (ELN) Human Genome Sciences (HGSI) Theravance (THRX) Vertex (VRTX) Seattle Genetics (SGEN) CompuGen (CGEN) Prosensa (RNA) Sanofi (SNY) Tysabri ACADIA (ACAD) Merck (MRK) NANTKWEST (NK) HALOZYME (HALO) OSI (OSIP) Sanofi (SNA) Incyte (INCY) Galena (GALE) Ziofpharm (ZIOP) Roche (RHHBY) NEKTAR (NKTR)) Theravance Bio Pharma (TBPH) Human Longevity (HLI) Regeneron (REGN) Vitae Pharmaceuticals (VTAE) Bristol-Myers Squibb (BMY) Gilead (GILD) Genentech ARCA (ABIO) Trastuzumab-DM1 Onyx (ONXX) SERES THERAPEUTICS (MCRB) Revlimid (lenolidamide) galapagos (GLPG) Biocryst (BCRX) Ionis (IONS) Auspex (ASPX) Zerenex Intermune (ITMN) REGULUS (RGLS) BIOMARIN (BMRN) Xoma (XOMA) Micromet (MITI) Sanofi-Aventis (SAN) Alder Biopharmaceuticals (ALDR) ABBVIE (ABBV)